Protocol Search

Protocol No.

PSCI-17-070

Prinicipal Investigator

Aregawi, Dawit

Phase

Phase II

Age Group

Adult

Scope

National

Secondary Protocol No.

ML29496, OHSU eIRB11601

Title

Maintenance Obinutuzumab for Primary Central Nervous System Lymphoma Complete Responders

Objective

To determine the effect of maintenance obinutuzumab on duration of complete response (CR) in
patients with CD20+B-cell PCNSL who attain CR to first-line treatment with high-dose methotrexate-based chemotherapy.

Applicable Disease Sites

Brain and Nervous System

Status

Open

Participating Institutions

Hershey Medical Center